Treatment of acute hallucinogenic drug toxicity: specific pharmacological intervention.
D000661:Amphetamine / Q000506:poisoning; D000931:Antidotes / Q000627:therapeutic use*; D001532:Atropa belladonna / Q000506:poisoning; D002188:Cannabis / Q000506:poisoning; D002746:Chlorpromazine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D013759:Dronabinol / Q000506:poisoning; D006213:Hallucinogens / Q000506:poisoning*; D006801:Humans; D007211:Indoles / Q000506:poisoning; D008238:Lysergic Acid Diethylamide / Q000506:poisoning; D008635:Mescaline / Q000506:poisoning; D010276:Parasympatholytics / Q000506:poisoning; D010622:Phencyclidine; D010627:Phenethylamines / Q000506:poisoning; D010640:Phenothiazines / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012601:Scopolamine / Q000506:poisoning; D019966:Substance-Related Disorders; D014363:Tryptamines / Q000506:poisoning
D000931:Antidotes; D006213:Hallucinogens; D007211:Indoles; D010276:Parasympatholytics; D010627:Phenethylamines; D010640:Phenothiazines; D014363:Tryptamines; D013759:Dronabinol; D008238:Lysergic Acid Diethylamide; D010830:Physostigmine; D000661:Amphetamine; D012601:Scopolamine; D010622:Phencyclidine; D003975:Diazepam; D008635:Mescaline; D002746:Chlorpromazine